Ha Nguyen Thi Thu, Nghia Duong Trong, Nga Ha Thi Viet, Lua Trinh Thi, Hong Nguyen Thi Bich, Hanh Nguyen Thi, Ngoc Nguyen Kim, Vuong Nguyen Lam
Faculty of Traditional Medicine, Hanoi Medical University, Hanoi, Vietnam.
National Hospital of Traditional Medicine, Hanoi, Vietnam.
Integr Med Res. 2025 Jun;14(2):101143. doi: 10.1016/j.imr.2025.101143. Epub 2025 Mar 31.
Knee osteoarthritis (KOA) is a leading cause of disability among older adults worldwide. Traditional medicine offers a promising treatment for KOA with fewer side effects compared to current treatments such as non-steroidal anti-inflammatory drugs and corticosteroids. This study aimed to evaluate the safety and efficacy of TD0015, a herbal formulation based on the Duhuo Jisheng decoction, in treating KOA.
This randomized, double-blind, placebo-controlled trial enrolled 108 patients with KOA. Participants were randomly assigned in a 1:1:1 ratio to receive TD0015 5 g, TD0015 7.5 g, or placebo daily for 60 days. Efficacy endpoints included changes in Western Ontario and McMaster Universities Osteoarthritis index (WOMAC), Visual Analogue Scale (VAS), Lequesne index, heel-buttock distance, and knee flexion and extension range of motion. Safety was assessed by adverse events (AEs).
The mean age was around 60 years, and >80 % were females. Both TD0015 treatment groups significantly improved the WOMAC, VAS, Lequesne score, heel-buttock distance, and knee flexion and extension during the treatment period. At the 90-day follow-up, the mean percentage improvement in WOMAC scores was 74.5 % ± 13.4 %, 83.9 % ± 14.8 %, and 7.4 % ± 31.5 % in the TD0015 5 g, TD0015 7.5 g, and placebo groups, respectively, which corresponds to a 67.1 % (95 % CI: 56.3-77.9) and 76.5 % (95 % CI: 65.6-87.4) improvement in the TD0015 5 g and TD0015 7.5 g groups, compared to placebo. No AEs were reported in any group.
The Vietnamese herbal medicine TD0015 is safe, efficacious, and well-tolerated in treating KOA. Further studies are required to confirm the long-term efficacy and safety of TD0015.
ClinicalTrials.gov, NCT06657495.
膝关节骨关节炎(KOA)是全球老年人残疾的主要原因。与目前的治疗方法如非甾体抗炎药和皮质类固醇相比,传统医学为KOA提供了一种有前景的治疗方法,且副作用更少。本研究旨在评估基于独活寄生汤的草药配方TD0015治疗KOA的安全性和有效性。
这项随机、双盲、安慰剂对照试验纳入了108例KOA患者。参与者按1:1:1的比例随机分配,每天接受5克TD0015、7.5克TD0015或安慰剂,共60天。疗效终点包括西安大略和麦克马斯特大学骨关节炎指数(WOMAC)、视觉模拟量表(VAS)、Lequesne指数、足跟-臀部距离以及膝关节屈伸活动范围的变化。通过不良事件(AE)评估安全性。
平均年龄约为60岁,超过80%为女性。在治疗期间,两个TD0015治疗组均显著改善了WOMAC、VAS、Lequesne评分、足跟-臀部距离以及膝关节屈伸。在90天随访时,TD0015 5克组、TD0015 7.5克组和安慰剂组的WOMAC评分平均改善百分比分别为74.5%±13.4%、83.9%±14.8%和7.4%±31.5%,与安慰剂相比,TD0015 5克组和TD0015 7.5克组分别改善了67.1%(95%CI:56.3-77.9)和76.5%(95%CI:65.6-87.4)。各组均未报告不良事件。
越南草药TD0015治疗KOA安全、有效且耐受性良好。需要进一步研究来证实TD0015的长期疗效和安全性。
ClinicalTrials.gov,NCT06657495。